Panbela Therapeutics (PBLA) News Today $0.37 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Panbela Therapeutics (NASDAQ:PBLA) Stock Price Up 2.4% - Here's WhyOctober 23, 2024 | americanbankingnews.comPanbela Therapeutics (OTC:PBLA) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comHorace Mann Educators (NYSE:HMN) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comPanbela Therapeutics (OTC:PBLA) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comPanbela Therapeutics, Inc. (NASDAQ:PBLA) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | insidermonkey.comPanbela Therapeutics, Inc. (PBLA) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comPanbela Provides Business Update and Reports Q2 2024 Financial ResultsAugust 13, 2024 | globenewswire.comPanbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024July 30, 2024 | globenewswire.comPanbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial ModificationJune 24, 2024 | globenewswire.comPanbela Therapeutics Inc. (PBLA) Insider ActivityMay 25, 2024 | nasdaq.comHC Wainwright & Co. Downgrades Panbela Therapeutics (PBLA)May 17, 2024 | msn.comQ1 2024 Panbela Therapeutics Inc Earnings CallMay 16, 2024 | uk.finance.yahoo.comPanbela Therapeutics, Inc. (NASDAQ:PBLA) Q1 2024 Earnings Call TranscriptMay 16, 2024 | msn.comPanbela Therapeutics Inc (PBLA) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...May 16, 2024 | finance.yahoo.comPanbela Provides Business Update and Reports Q1 2024 Financial ResultsMay 15, 2024 | globenewswire.comPanbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and SulindacMay 6, 2024 | finance.yahoo.comPanbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and SulindacMay 6, 2024 | globenewswire.comPanbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024May 1, 2024 | globenewswire.comAcceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease WeekApril 30, 2024 | globenewswire.comPanbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025April 22, 2024 | globenewswire.comPanbela Applies to List on CBOEApril 18, 2024 | marketwatch.comPanbela Announces Poster Presentation at American Association for Cancer Research:April 18, 2024 | globenewswire.comPanbela Therapeutics, Inc.: Panbela Announces Transfer to OTCQB MarketApril 17, 2024 | finanznachrichten.dePanbela Announces Transfer to OTCQB MarketApril 16, 2024 | finance.yahoo.comRecap: Panbela Therapeutics Q4 EarningsMarch 28, 2024 | benzinga.comPanbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | seekingalpha.comPanbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | msn.comPanbela Therapeutics, Inc.: Panbela Provides Business Update and Reports Q4 and FY 2024 Financial ResultsMarch 27, 2024 | finanznachrichten.dePanbela Provides Business Update and Reports Q4 and FY 2024 Financial ResultsMarch 26, 2024 | globenewswire.comEarnings Preview: Panbela TherapeuticsMarch 26, 2024 | benzinga.comPBLA Panbela Therapeutics, Inc.March 22, 2024 | seekingalpha.comPanbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024March 12, 2024 | globenewswire.comTop 4 Health Care Stocks That Are Preparing To Pump This MonthFebruary 23, 2024 | msn.comTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)February 23, 2024 | benzinga.comPanbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares RequirementsFebruary 15, 2024 | finance.yahoo.comPanbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares RequirementsFebruary 15, 2024 | globenewswire.comPanbela Announces Closing of Approximately $9.0 Million Public OfferingFebruary 1, 2024 | finance.yahoo.comPanbela Therapeutics Inc (PBLA)January 31, 2024 | investing.comPanbela Therapeutics, Inc.: Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)January 30, 2024 | finanznachrichten.deWhat's Going On With Panbela Therapeutics Stock Today?January 30, 2024 | benzinga.comAcceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)January 30, 2024 | finance.yahoo.comPanbela Therapeutics, Processa Pharmaceuticals among healthcare moversJanuary 29, 2024 | msn.comPanbela Therapeutics Prices $9 Mln Share OfferingJanuary 29, 2024 | markets.businessinsider.comWhy Is Panbela Therapeutics (PBLA) Stock Down 63% Today?January 29, 2024 | investorplace.comPanbela Therapeutics Shares Slide Premarket After Public OfferingJanuary 29, 2024 | marketwatch.comPanbela Therapeutics drops on $9M public offeringJanuary 29, 2024 | msn.comPanbela Announces Pricing of Approximately $9.0 Million Public OfferingJanuary 29, 2024 | finance.yahoo.comWhat's Going On With Panbela Therapeutics Stock?January 26, 2024 | msn.comTrading was temporarily halted for "PBLA" at 09:01 AM with a stated reason of "LULD pause."January 26, 2024 | marketbeat.comPanbela Exceeds 50% Enrollment for Aspire Trial in Pancreatic Cancer, Exceeding Anticipated Timelines with Accelerated MomentumJanuary 25, 2024 | finance.yahoo.com Get Panbela Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PBLA and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words… All you have to do is claim your free ticket to the event now… PBLA Media Mentions By Week PBLA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBLA News Sentiment▼0.000.44▲Average Medical News Sentiment PBLA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBLA Articles This Week▼01▲PBLA Articles Average Week Get Panbela Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PBLA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GeoVax Labs News Today BioCardia News Today IM Cannabis News Today Hoth Therapeutics News Today Lixte Biotechnology News Today 180 Life Sciences News Today Pasithea Therapeutics News Today Vaccinex News Today CERo Therapeutics News Today Synaptogenix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBLA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
